MANSFIELD, Mass.--(BUSINESS WIRE)--Jun. 4, 2013--
(NYSE: COV), a leading global provider of healthcare products, will
present at the Goldman Sachs 34th Global Healthcare Conference in Rancho
Palos Verdes, CA, on Wednesday, June 12, 2013.
José E. Almeida, Chairman, President and Chief Executive Officer, will
represent the Company in a session scheduled to begin at 12:20 p.m. ET.
Mark Trudeau, President, Pharmaceuticals, will discuss Mallinckrodt, the
pharmaceuticals business of Covidien, in a session scheduled to begin at
4:20 p.m. ET.
A live audio webcast of the presentations can be accessed at Covidien’s
Investor Relations website: http://investor.covidien.com.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000
employees worldwide in 70 countries, and its products are sold in over
140 countries. Please visit www.covidien.com
to learn more about our business.
Jacqueline Strayer, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343